• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PERCUFLEX PLUS; CATHETER, BILIARY, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PERCUFLEX PLUS; CATHETER, BILIARY, DIAGNOSTIC Back to Search Results
Model Number M0061752630
Device Problems Calcified (1077); Difficult to Remove (1528); Use of Device Problem (1670); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Sepsis (2067)
Event Date 11/01/2023
Event Type  Injury  
Manufacturer Narrative
Block b3: date of event was approximated to november 1, 2023 based on the date the manufacturer became aware of the event.Block e1: initial reporter city: (b)(6).Block h6: imdrf device code a150207 captures the reportable event of stent difficult to remove.Imdrf device code a040501 captures the reportable event of stent calcified.Imdrf device code a23 captures the reportable event of device misuse.Imdrf patient code e0306 captures the reportable event of sepsis.Imdrf impact code f23 captures the reportable event of unexpected medical intervention.Imdrf impact code f2301 captures the reportable event of additional device required.
 
Event Description
It was reported to boston scientific corporation that a percuflex plus ureteral stent was successfully implanted during a procedure.The event date was unknown.After three months of being implanted, during a planned stone removal, it was noted that the stent was found encrusted.It was mentioned that a laser was used to remove the encrustation, and it took them four hours to remove the stent using a standard steel gripper.The procedure was successfully completed with a non-boston scientific device.A photo of the complaint device was provided and showed the stent was calcified.The patient developed sepsis and is now in the palliative department.No other medications were given.
 
Manufacturer Narrative
Block b3: date of event was approximated to november 1, 2023 based on the date the manufacturer became aware of the event.Block e1: initial reporter city: (b)(6).Block h6: imdrf device code a040501 captures the reportable event of stent calcified.Imdrf patient code e0306 captures the reportable event of sepsis.Update to block b5: additional information received on 01dec2023, that the problem happened with a timespan within the last six months.
 
Event Description
It was reported to boston scientific corporation that a percuflex plus ureteral stent was successfully implanted during a procedure.The event date was unknown.After three months of being implanted, during a planned stone removal, it was noted that the stent was found encrusted.It was mentioned that a laser was used to remove the encrustation, and it took them four hours to remove the stent using a standard steel gripper.The procedure was successfully completed with a non-boston scientific device.A photo of the complaint device was provided and showed the stent was calcified.The patient developed sepsis and is now in the palliative department.No other medications were given.Additional information received that the problem happened with a timespan within the last six months.
 
Manufacturer Narrative
Block b3: date of event was approximated to november 1, 2023 based on the date the manufacturer became aware of the event.Block e1: initial reporter city: (b)(6).Block h6: imdrf device code a040501 captures the reportable event of stent calcified.Imdrf patient code e0306 captures the reportable event of sepsis.Update to block b5: additional information received on 01dec2023, that the problem happened with a timespan within the last six months.Block h10: the returned percuflex plus ureteral stent was analyzed, and a visual and microscopic evaluation noted that both coils and the shaft were calcified.During media inspection, a photo was attached and shows calcification; however, individual complaint information was not specified.No other problems with the device were noted.The reported event of stent calcified and stent difficult to remove are confirmed.Taking all available information into consideration, due to the calcified stent, it is possible to confirm the difficult to removed reported by the customer.Regarding the sepsis reported, it is a known adverse event associated with the use of the device, additionally, the patient or impact code reported are a condition that could not be tested, analyzed or replicated on the product analysis laboratory.Therefore, the as analyzed cause code for this issue will be known inherent risk of device.For the use of device issue-misuse, due to information provided, it can be concluded that the device was intentionally indwelling past 90 days without evaluation resulting in an encrustation of the stent and difficult removal.Therefore, all compiled information on this investigation determines that the most probable cause is failure to follow instructions since problems traced to the user not following the manufacturer's instructions.
 
Event Description
It was reported to boston scientific corporation that a percuflex plus ureteral stent was successfully implanted during a procedure.The event date was unknown.After three months of being implanted, during a planned stone removal, it was noted that the stent was found encrusted.It was mentioned that a laser was used to remove the encrustation, and it took them four hours to remove the stent using a standard steel gripper.The procedure was successfully completed with a non-boston scientific device.A photo of the complaint device was provided and showed the stent was calcified.The patient developed sepsis and is now in the palliative department.No other medications were given.Additional information received that the problem happened with a timespan within the last six months.
 
Manufacturer Narrative
Block b3: date of event was approximated to (b)(6) 2023 based on the date the manufacturer became aware of the event.Block e1: initial reporter city: (b)(6).Block h6: imdrf device code a040501 captures the reportable event of stent calcified.Imdrf patient code e0306 captures the reportable event of sepsis.Update to block h10: the returned percuflex plus ureteral stent was analyzed, and a visual and microscopic evaluation noted that both coils and the shaft were calcified.During media inspection, a photo was attached and shows calcification; however, individual complaint information was not specified.No other problems with the device were noted.The reported event of stent calcified and stent difficult to remove are confirmed.Taking all available information into consideration, due to the calcified stent, it is possible to confirm the difficult to removed reported by the customer.Regarding the sepsis reported, it is a known adverse event associated with the use of the device, additionally, the patient or impact code reported are a condition that could not be tested, analyzed or replicated on the product analysis laboratory.Additionally, the impact codes additional device required and unexpected medical intervention were caused due to the complaint events reported.Therefore, the as analyzed cause code for this issue will be known inherent risk of device.For the use of device issue-misuse, due to information provided, it can be concluded that the device was intentionally indwelling past 90 days without evaluation resulting in an encrustation of the stent and difficult removal.Therefore, all compiled information on this investigation determines that the most probable cause is failure to follow instructions since problems traced to the user not following the manufacturer's instructions.
 
Event Description
It was reported to boston scientific corporation that a percuflex plus ureteral stent was successfully implanted during a procedure.The event date was unknown.After three months of being implanted, during a planned stone removal, it was noted that the stent was found encrusted.It was mentioned that a laser was used to remove the encrustation, and it took them four hours to remove the stent using a standard steel gripper.The procedure was successfully completed with a non-boston scientific device.A photo of the complaint device was provided and showed the stent was calcified.The patient developed sepsis and is now in the palliative department.No other medications were given.Additional information received that the problem happened with a timespan within the last six months.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCUFLEX PLUS
Type of Device
CATHETER, BILIARY, DIAGNOSTIC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
2546 calle primera
alajuela
CS  
Manufacturer Contact
farshad fahimi
4100 hamline avenue north
building c
saint paul, MN 55112
MDR Report Key18312707
MDR Text Key330299088
Report Number2124215-2023-68507
Device Sequence Number1
Product Code FAD
UDI-Device Identifier08714729041184
UDI-Public08714729041184
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
K924608
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 05/24/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberM0061752630
Device Catalogue Number175-263
Device Lot Number0030864362
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/12/2023
Supplement Dates Manufacturer Received12/01/2023
01/10/2024
04/29/2024
Supplement Dates FDA Received12/27/2023
02/05/2024
05/24/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/17/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age40 YR
Patient SexFemale
-
-